244 related articles for article (PubMed ID: 17567233)
1. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
2. Consumer response to dual incentives under multitiered prescription drug formularies.
Gilman BH; Kautter J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
[TBL] [Abstract][Full Text] [Related]
3. Effect of a medication copayment increase in veterans with schizophrenia.
Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
[TBL] [Abstract][Full Text] [Related]
4. Copayments for medications after June 30, 2010. Final rule.
Department of Veterans Affairs
Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
[TBL] [Abstract][Full Text] [Related]
5. Effect of increased copayments on pharmacy use in the Department of Veterans Affairs.
Stroupe KT; Smith BM; Lee TA; Tarlov E; Durazo-Arvizu R; Huo Z; Barnett T; Cao L; Burk M; Cunningham F; Hynes DM; Weiss KB
Med Care; 2007 Nov; 45(11):1090-7. PubMed ID: 18049350
[TBL] [Abstract][Full Text] [Related]
6. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
7. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
8. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
9. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
[TBL] [Abstract][Full Text] [Related]
10. Incentive formularies and changes in prescription drug spending.
Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
[TBL] [Abstract][Full Text] [Related]
11. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
Mager DE; Cox ER
Am J Manag Care; 2007 Jun; 13(6 Pt 2):347-52. PubMed ID: 17567235
[TBL] [Abstract][Full Text] [Related]
12. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
13. Copayments for medications. Interim final rule.
Department of Veterans Affairs
Fed Regist; 2009 Dec; 74(250):69283-5. PubMed ID: 20169681
[TBL] [Abstract][Full Text] [Related]
14. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
Kostova D; Fox J
Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
[TBL] [Abstract][Full Text] [Related]
15. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
16. Copayments for medications in 2012. Final rule.
Department of Veterans Affairs
Fed Regist; 2012 May; 77(93):28258-9. PubMed ID: 22606731
[TBL] [Abstract][Full Text] [Related]
17. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
[TBL] [Abstract][Full Text] [Related]
18. Controlling prescription drug expenditures: a report of success.
Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
[TBL] [Abstract][Full Text] [Related]
19. Copayments for prescription medicines on a public health insurance scheme in Ireland.
Sinnott SJ; Normand C; Byrne S; Woods N; Whelton H
Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):695-704. PubMed ID: 26696242
[TBL] [Abstract][Full Text] [Related]
20. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
